Robert Reinhard, Université de Montréal

Research

Biological Sampling Capacity Building Global Health Hiv Cure And Remission Hiv Treatment Immunotherapy Public Engagement

Latest papers

The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research.
Journal of virus eradication · 2017

All 1 publications

Latest funding

Targeting mTOR to restore mucosal immunity toward remission in HIV-infected individuals
CIHR · 2017 · Co-investigator
$250,000
Advancing Public Engagement in Canadian HIV Cure Research
CIHR · 2015 · Principal investigator
$15,000
The Canadian HIV Cure Enterprise (CanCURE)
CIHR · 2013 · Co-investigator
$8,569,071

All 3 grants and awards

1 publications.

01

The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research.

Mehraj V, Ghali P, Ramendra R, Costiniuk C, Lebouché B, Ponte R, Reinhard R, Sousa J, Chomont N, Cohen EA, Ancuta P, Routy JP

Journal of virus eradication2017

DOI: 10.1016/s2055-6640(20)30316-2 PMID: 29057085

Targeting mTOR to restore mucosal immunity toward remission in HIV-infected individuals

Co-investigatorCIHR2017Operating Grant: Innovative Biomedical and Clinical HIV/AIDS Research

Principal investigators: Ancuta, Petronela; Routy, Jean-Pierre

Keywords: Cd4+ T-Cells; Flow Cytometry; Genome-Wide Transcriptional Profiling; Hiv Reservoirs; Hiv-1; Mammalian Target Of Rapamycin; Microscopy; Mucosal Immunity; Rna Interference; Th17 Cells

$250,000

Advancing Public Engagement in Canadian HIV Cure Research

Principal investigatorCIHR2015Planning and Dissemination Grant - Institute Community Support

Principal investigators: Cohen, Eric A; Margolese, Shari L; Masching, Renee; Mbulaheni, Tola; Rosenes, Ron; Tharao, Wangari E; Reinhard, Robert J

Keywords: Biological Sampling; Capacity Building; Global Health; Hiv Cure And Remission; Hiv Treatment; Immunotherapy; Public Engagement

$15,000

The Canadian HIV Cure Enterprise (CanCURE)

Co-investigatorCIHR2013Team Grant: Canadian Initiative for HIV Cure Research

Principal investigators: Cohen, Eric A; Ancuta, Petronela; Angel, Jonathan B; Estaquier, Jérôme; Fowke, Keith R; Mouland, Andrew J; Ostrowski, Mario A; Routy, Jean-Pierre; Tremblay, Michel J

Keywords: Cd4+ T Lymphocytes And Myeloid Cells; Hiv Cure; Hiv Eradication; Hiv Latency; Hiv Persistence; Human Trials; Humanized Blt Mice Model; Immune-Based Therapies; Non Human Primate Model; Oncolytic Viruses

$8,569,071

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Microbiologie et immunologie
Rheumatology
Microbiology and Immunology
Medicine
Other

Co-authors at Université de Montréal, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Nicolas Chomont

Microbiologie et immunologie

1 shared papers, latest 2017

Cecilia Costiniuk

Rheumatology

1 shared papers, latest 2017

Nicolas Chomont

Faculty

1 shared papers, latest 2017

Cecilia Costiniuk

Faculty

1 shared papers, latest 2017

Jean-Pierre Routy

Medicine

1 shared papers, latest 2017

Petronela Ancuta

Microbiologie et immunologie

1 shared papers, latest 2017

Jean-Pierre Routy

Microbiology and Immunology

1 shared papers, latest 2017

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student: Biological Sampling Dear Professor Reinhard, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research." (2017), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]